Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Oct;22(4):560–563. doi: 10.1128/aac.22.4.560

Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.

H C Neu, T Kamimura
PMCID: PMC183793  PMID: 7181471

Abstract

Fosmidomycin (FR-31564), a phosphonic acid derivative, was combined with cefazolin, cephalexin, ampicillin, carbenicillin, ticarcillin, gentamicin, and trimethoprim. Synergy between fosmidomycin and penicillins or cephalosporins was found for 37 to 52% of the Enterobacteriaceae tested. Synergy with trimethoprim was found against 55% of bacteria isolated, but only 17% of the strains showed synergy between formidomycin and gentamicin. Synergy between fosmidomycin and ticarcillin was shown for 35% of the Pseudomonas isolates. Cefazolin-, ampicillin-, and gentamicin-resistant isolates of various species were synergistically inhibited by fosmidomycin, as were ticarcillin- and gentamicin-resistant isolates. Antagonism was not encountered. This study illustrates another example of synergistic activity of compounds which attack different mechanisms in bacterial cells.

Full text

PDF
560

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daza R., Moreno-López M., Dámaso D. Interactions of fosfomycin with other antibiotics. Chemotherapy. 1977;23 (Suppl 1):86–92. doi: 10.1159/000222031. [DOI] [PubMed] [Google Scholar]
  2. Kojo H., Shigi Y., Nishida M. FR-31564, a new phosphonic acid antibiotic: bacterial resistance and membrane permeability. J Antibiot (Tokyo) 1980 Jan;33(1):44–48. doi: 10.7164/antibiotics.33.44. [DOI] [PubMed] [Google Scholar]
  3. Mine Y., Kamimura T., Nonoyama S., Nishida M., Goto S., Kuwahara S. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic. J Antibiot (Tokyo) 1980 Jan;33(1):36–43. doi: 10.7164/antibiotics.33.36. [DOI] [PubMed] [Google Scholar]
  4. Neu H. C., Kamimura T. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent. Antimicrob Agents Chemother. 1981 Jun;19(6):1013–1023. doi: 10.1128/aac.19.6.1013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Neu J. C. Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics. Antimicrob Agents Chemother. 1976 Sep;10(3):535–542. doi: 10.1128/aac.10.3.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Olay T., Rodríguez A., Oliver L. E., Vicente M. V., Quecedo M. C. Interaction of fosfomycin with other antimicrobial agents: in vitro and in vivo studies. J Antimicrob Chemother. 1978 Nov;4(6):569–576. doi: 10.1093/jac/4.6.569. [DOI] [PubMed] [Google Scholar]
  7. Perea E. J., Torres M. A., Borobio M. V. Synergism of fosfomycin-ampicillin and fosfomycin-chloramphenicol against Salmonella and Shigella. Antimicrob Agents Chemother. 1978 May;13(5):705–709. doi: 10.1128/aac.13.5.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Yokota Y., Murakawa T., Nishida M. In vitro synergism of FR-31564, a new phosphonic acid antibiotic. J Antibiot (Tokyo) 1981 Jul;34(7):876–883. doi: 10.7164/antibiotics.34.876. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES